Trastuzumab emtansine (solution), CAS [[1018448-65-1]]

Produktübersicht

• Artikelname: Trastuzumab emtansine (solution), CAS [[1018448-65-1]]
• Artikelnummer: MCE-HY-P9921A
• Hersteller Artikelnummer: HY-P9921A
• Alternativnummer: MCE-HY-P9921A-50MG,MCE-HY-P9921A-10MG,MCE-HY-P9921A-1MG,MCE-HY-P9921A-5MG,MCE-HY-P9921A-25MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: Ado-Trastuzumab emtansine (solution) , PRO132365 (solution) , T-DM 1 (solution)

Produktbeschreibung

Trastuzumab emtansine (Ado-Trastuzumab emtansine) is an antibody-drug conjugate (ADC) that incorporates the HER2-targeted antitumor properties of trastuzumab with the cytotoxic activity of the microtubule-inhibitory agent DM1 (derivative of maytansine), and the drug-linker conjugate for ADC is SMCC-DM1 (HY-101070). Trastuzumab emtansine can be used for the research of advanced breast cancer[1][2].

Produkteigenschaften

• Molekulargewicht: 149114 (average)
• Reinheit: 98.27
• CAS Nummer: [1018448-65-1]
• Target-Kategorie: Antibody-Drug Conjugates (ADCs),EGFR

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: ADC Related